Private equity groups have displayed significant interest in cardiology over the last several years as the specialty sees a rise in outpatient growth and demand for cardiovascular services remains high among U.S. patients.
In January, PE Hub reported on several PE-backed deals over the last two years that have shaped consolidation in cardiology:
1. RTI Surgical and Collagen Solutions: Alachua, Fla.-based RTI Surgical, a contract development and management organization focused on regenerative medicine, acquired Eden Prairie, Minn.-based Collagen Solutions in October 2024. Collagen Solutions produces medical-grade collagen and xenograft tissue for cardiac applications. RTI Surgical was acquired in 2020 by London-based Montagu Private Equity.
2. IK Partners invests in Defibrion: In July 2024, London-based PE firm IK Partners announced it had acquired a stake in Defibrion, a distributor of automated external defibrillators, from existing shareholders.
3. WindRose Health Investors acquires CardioOne: In March 2024, WindRose Health Investors, a New York City-based PE firm, completed its acquisition of CardioOne, a physician-aligned, cardiology-focused management services organization that supports independent cardiology practices.
4. Pharos Capital acquires RhythMedix: In January 2024, Dallas- and Nashville, Tenn.-based Pharos Capital acquired RhythMedix, a cardiac monitoring systems maker based in Mount Laurel, N.J.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
